Literature DB >> 15800181

Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus.

Giambattista Bonanno1, Roberto Giambelli, Luca Raiteri, Ettore Tiraboschi, Simona Zappettini, Laura Musazzi, Maurizio Raiteri, Giorgio Racagni, Maurizio Popoli.   

Abstract

Glutamate neurotransmission was recently implicated in the action of stress and in antidepressant mechanisms. We report that chronic (not acute) treatment with three antidepressants with different primary mechanisms (fluoxetine, reboxetine, and desipramine) markedly reduced depolarization-evoked release of glutamate, stimulated by 15 or 25 mm KCl, but not release of GABA. Endogenous glutamate and GABA release was measured in superfused synaptosomes, freshly prepared from hippocampus of drug-treated rats. Interestingly, treatment with the three drugs only barely changed the release of glutamate (and of GABA) induced by ionomycin. In synaptic membranes of chronically treated rats we found a marked reduction in the protein-protein interaction between syntaxin 1 and Thr286-phosphorylated alphaCaM kinase II (alpha-calcium/calmodulin-dependent protein kinase II) (an interaction previously proposed to promote neurotransmitter release) and a marked increase in the interaction between syntaxin 1 and Munc-18 (an interaction proposed to reduce neurotransmitter release). Furthermore, we found a selective reduction in the expression level of the three proteins forming the core SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) complex. These findings suggest that antidepressants work by stabilizing glutamate neurotransmission in the hippocampus and that they may represent a useful tool for the study of relationship between functional and molecular processes in nerve terminals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15800181      PMCID: PMC6724889          DOI: 10.1523/JNEUROSCI.5033-04.2005

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  63 in total

Review 1.  Antidepressants for the new millennium.

Authors:  P Skolnick
Journal:  Eur J Pharmacol       Date:  1999-06-30       Impact factor: 4.432

Review 2.  Role of high-affinity receptors and membrane transporters in nonsynaptic communication and drug action in the central nervous system.

Authors:  E S Vizi
Journal:  Pharmacol Rev       Date:  2000-03       Impact factor: 25.468

Review 3.  Second messenger-regulated protein kinases in the brain: their functional role and the action of antidepressant drugs.

Authors:  M Popoli; N Brunello; J Perez; G Racagni
Journal:  J Neurochem       Date:  2000-01       Impact factor: 5.372

4.  Changes of synaptotagmin interaction with t-SNARE proteins in vitro after calcium/calmodulin-dependent phosphorylation.

Authors:  M Verona; S Zanotti; T Schäfer; G Racagni; M Popoli
Journal:  J Neurochem       Date:  2000-01       Impact factor: 5.372

Review 5.  Synapsins as regulators of neurotransmitter release.

Authors:  S Hilfiker; V A Pieribone; A J Czernik; H T Kao; G J Augustine; P Greengard
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-02-28       Impact factor: 6.237

Review 6.  Stress and hippocampal plasticity.

Authors:  B S McEwen
Journal:  Annu Rev Neurosci       Date:  1999       Impact factor: 12.449

7.  A late phase of exocytosis from synaptosomes induced by elevated [Ca2+]i is not blocked by Clostridial neurotoxins.

Authors:  A C Ashton; J O Dolly
Journal:  J Neurochem       Date:  2000-05       Impact factor: 5.372

8.  Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression.

Authors:  Y I Sheline; M Sanghavi; M A Mintun; M H Gado
Journal:  J Neurosci       Date:  1999-06-15       Impact factor: 6.167

9.  Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression.

Authors:  G Rajkowska; J J Miguel-Hidalgo; J Wei; G Dilley; S D Pittman; H Y Meltzer; J C Overholser; B L Roth; C A Stockmeier
Journal:  Biol Psychiatry       Date:  1999-05-01       Impact factor: 13.382

10.  nSec1 binds a closed conformation of syntaxin1A.

Authors:  B Yang; M Steegmaier; L C Gonzalez; R H Scheller
Journal:  J Cell Biol       Date:  2000-01-24       Impact factor: 10.539

View more
  62 in total

Review 1.  Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders.

Authors:  Cagri Yüksel; Dost Öngür
Journal:  Biol Psychiatry       Date:  2010-08-21       Impact factor: 13.382

2.  Activation of the mGlu7 receptor elicits antidepressant-like effects in mice.

Authors:  Agnieszka Palucha; Kinga Klak; Piotr Branski; Herman van der Putten; Peter J Flor; Andrzej Pilc
Journal:  Psychopharmacology (Berl)       Date:  2007-07-12       Impact factor: 4.530

3.  Targeting glial physiology and glutamate cycling in the treatment of depression.

Authors:  Gerald W Valentine; Gerard Sanacora
Journal:  Biochem Pharmacol       Date:  2009-04-17       Impact factor: 5.858

Review 4.  Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders.

Authors:  Gerard Sanacora; Giulia Treccani; Maurizio Popoli
Journal:  Neuropharmacology       Date:  2011-08-03       Impact factor: 5.250

Review 5.  Review of pharmacological treatment in mood disorders and future directions for drug development.

Authors:  Xiaohua Li; Mark A Frye; Richard C Shelton
Journal:  Neuropsychopharmacology       Date:  2011-09-07       Impact factor: 7.853

6.  Acute desipramine restores presynaptic cortical defects in murine experimental autoimmune encephalomyelitis by suppressing central CCL5 overproduction.

Authors:  Silvia Di Prisco; Elisa Merega; Massimiliano Lanfranco; Simona Casazza; Antonio Uccelli; Anna Pittaluga
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

Review 7.  Rapid-onset antidepressant efficacy of glutamatergic system modulators: the neural plasticity hypothesis of depression.

Authors:  Jing Wang; Liang Jing; Juan-Carlos Toledo-Salas; Lin Xu
Journal:  Neurosci Bull       Date:  2014-12-06       Impact factor: 5.203

8.  Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism.

Authors:  Valentina Gigliucci; Grainne O'Dowd; Sheena Casey; Danielle Egan; Sinead Gibney; Andrew Harkin
Journal:  Psychopharmacology (Berl)       Date:  2013-03-02       Impact factor: 4.530

Review 9.  Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders.

Authors:  Rodrigo Machado-Vieira; Giacomo Salvadore; Lobna A Ibrahim; Nancy Diaz-Granados; Carlos A Zarate
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

Review 10.  Neurovascular glucocorticoid receptors and glucocorticoids: implications in health, neurological disorders and drug therapy.

Authors:  Sherice Williams; Chaitali Ghosh
Journal:  Drug Discov Today       Date:  2019-09-18       Impact factor: 7.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.